@orcabio.bsky.social
Lauren Smith, Orca Bio’s Chief Quality Officer, will speak on the Women in Leadership panel at the 9th Annual American Pharma Manufacturing and Outsourcing Summit. It will cover navigating career challenges and the importance of building strong networks to shape impactful careers. bit.ly/4p8j65U
November 17, 2025 at 5:31 PM
Lauren Smith, Orca Bio’s Chief Quality Officer, will speak on the Women in Leadership panel at the 9th Annual American Pharma Manufacturing and Outsourcing Summit. It will cover navigating career challenges and the importance of building strong networks to shape impactful careers. bit.ly/4p8j65U
It's #NationalMarrowAwarenessMonth, a time to celebrate the donors who make life-saving treatments possible & the patients, families & care teams whose courage & support inspires our work.
Join registries like @nmdp-org.bsky.social & you could be the match that gives someone a 2nd chance at life.
Join registries like @nmdp-org.bsky.social & you could be the match that gives someone a 2nd chance at life.
November 14, 2025 at 10:48 PM
It's #NationalMarrowAwarenessMonth, a time to celebrate the donors who make life-saving treatments possible & the patients, families & care teams whose courage & support inspires our work.
Join registries like @nmdp-org.bsky.social & you could be the match that gives someone a 2nd chance at life.
Join registries like @nmdp-org.bsky.social & you could be the match that gives someone a 2nd chance at life.
We are pleased to announce that Orca Bio will present new clinical data on our investigational high-precision cell therapies at the 67th American Society of Hematology Annual Meeting.
More on our #ASH25 presentations can be found here: bit.ly/47oB7qI
#bloodcancer #hematology #celltherapy
More on our #ASH25 presentations can be found here: bit.ly/47oB7qI
#bloodcancer #hematology #celltherapy
November 3, 2025 at 2:06 PM
We are pleased to announce that Orca Bio will present new clinical data on our investigational high-precision cell therapies at the 67th American Society of Hematology Annual Meeting.
More on our #ASH25 presentations can be found here: bit.ly/47oB7qI
#bloodcancer #hematology #celltherapy
More on our #ASH25 presentations can be found here: bit.ly/47oB7qI
#bloodcancer #hematology #celltherapy
Orca-T, our investigational allogeneic T-cell immunotherapy, is a finalist in the Biotech Innovation category of the Fierce Innovation Awards: Life Sciences Edition 2025!
This award recognizes the innovations pushing science forward. To learn more: orcabio.com
#FierceLifeSciencesAwards
This award recognizes the innovations pushing science forward. To learn more: orcabio.com
#FierceLifeSciencesAwards
October 29, 2025 at 10:51 PM
Orca-T, our investigational allogeneic T-cell immunotherapy, is a finalist in the Biotech Innovation category of the Fierce Innovation Awards: Life Sciences Edition 2025!
This award recognizes the innovations pushing science forward. To learn more: orcabio.com
#FierceLifeSciencesAwards
This award recognizes the innovations pushing science forward. To learn more: orcabio.com
#FierceLifeSciencesAwards
#TeamOrcaBio joined Blood Cancer United's #LightTheNight Silicon Valley. #LightTheNight provides a powerful platform to stand in solidarity with the community and raise critical funds. We are proud to partner with Blood Cancer United in our shared vision of ending blood cancer as we know it today!
October 21, 2025 at 9:50 PM
#TeamOrcaBio joined Blood Cancer United's #LightTheNight Silicon Valley. #LightTheNight provides a powerful platform to stand in solidarity with the community and raise critical funds. We are proud to partner with Blood Cancer United in our shared vision of ending blood cancer as we know it today!
Today, Orca Bio announced the FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T to treat hematological malignancies.
Read more in the press release: bit.ly/4q1Uzkw
#cansky #medsky #hemonc
Read more in the press release: bit.ly/4q1Uzkw
#cansky #medsky #hemonc
October 6, 2025 at 12:37 PM
Today, Orca Bio announced the FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T to treat hematological malignancies.
Read more in the press release: bit.ly/4q1Uzkw
#cansky #medsky #hemonc
Read more in the press release: bit.ly/4q1Uzkw
#cansky #medsky #hemonc
Orca Bio is proud to partner with NMDP and was honored to support this year’s Gala.
We had the privilege of witnessing a patient and donor meeting for the first time - a powerful reminder of the lives touched by this important cause and of the shared mission that unites us.
#cansky #medsky #hemonc
We had the privilege of witnessing a patient and donor meeting for the first time - a powerful reminder of the lives touched by this important cause and of the shared mission that unites us.
#cansky #medsky #hemonc
September 30, 2025 at 6:48 PM
This Blood Cancer Awareness Month, we join our partner Blood Cancer United in recognizing unmet needs across blood cancers and uniting for patients, families and caregivers.
BloodCancerUnited.org
#BCAM #cansky #medsky #celltherapy #AML
BloodCancerUnited.org
#BCAM #cansky #medsky #celltherapy #AML
September 9, 2025 at 6:40 PM
This Blood Cancer Awareness Month, we join our partner Blood Cancer United in recognizing unmet needs across blood cancers and uniting for patients, families and caregivers.
BloodCancerUnited.org
#BCAM #cansky #medsky #celltherapy #AML
BloodCancerUnited.org
#BCAM #cansky #medsky #celltherapy #AML
Orca Bio looks forward to presenting data on our investigational T-cell immunotherapy, Orca-T, at the upcoming @societyofhemonc.bsky.social Annual Meeting in Houston, Texas.
#cansky #medsky #SOHO2025 #hemonc
#cansky #medsky #SOHO2025 #hemonc
August 26, 2025 at 3:50 PM
Orca Bio looks forward to presenting data on our investigational T-cell immunotherapy, Orca-T, at the upcoming @societyofhemonc.bsky.social Annual Meeting in Houston, Texas.
#cansky #medsky #SOHO2025 #hemonc
#cansky #medsky #SOHO2025 #hemonc
Our CEO, Nathaniel Fernhoff, recently joined Erin Harris on an episode of Cell & Gene: The Podcast to talk about Orca Bio’s journey – from foundational research to advancing our lead investigational cell therapy, and the path toward potential commercialization: bit.ly/4fDkf28
#cansky #medsky
#cansky #medsky
Navigating the Journey to Safer Stem Cell Therapies with Orca Bio's Nate Fernhoff
Cell & Gene: The Podcast Host, Erin Harris, talks to Orca Bio CEO and Co-Founder Nathaniel Fernhoff as he recounts the company’s origins and evolution, tracing its roots to pioneering stem cell research at Stanford University and Dr. Irv Weissman's lab. Seeking to create safer, more effective cures for blood cancers such as AML, ALL, and MDS, Orca Bio developed high-precision cell therapies that utilize purified regulatory T cells and stem cells to minimize complications, such as graft-versus-host disease. Orca Bio spun out of academia to establish its own scalable production platform and clinical pipeline, and Fernhoff explains Orca's flagship product, Orca T, which recently achieved a pivotal milestone by outperforming standard stem cell transplants in a Phase 3 trial. Email Erin at [email protected] with topics you'd like us to cover in future episodes. -- #celltherapy #genetherapy Subscribe to the podcast! Apple - https://podcasts.apple.com/us/podcast/cell-gene-the-podcast/id1574496063 Spotify - https://open.spotify.com/show/78NSjRuHndVhI5VHWWAMya YouTube - https://music.youtube.com/playlist?list=PLFXsCNKV78rWyuxay7hXQFo0rVyAXAdwX
bit.ly
August 13, 2025 at 4:28 PM
Our CEO, Nathaniel Fernhoff, recently joined Erin Harris on an episode of Cell & Gene: The Podcast to talk about Orca Bio’s journey – from foundational research to advancing our lead investigational cell therapy, and the path toward potential commercialization: bit.ly/4fDkf28
#cansky #medsky
#cansky #medsky
Hi! We're excited to join the #Oncsky community. In 1H 2025, we shared the pivotal Phase 3 study results evaluating Orca-T, our lead investigational allogeneic T-cell immunotherapy, and announced the appointment of senior leaders as we advance toward commercialization. Stay tuned!
#cansky #medsky
#cansky #medsky
August 11, 2025 at 10:27 PM